BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer's Drug

Published on 27 Jan 2025 on Zacks · via Yahoo Finance

The FDA's approval is based on simulation data from multiple studies showing that maintenance dosing...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of Jim Cramer’s Thoughts on These 7 Stocks. In this article, we are...

Insider Monkey · via Yahoo Finance 1 Feb 2025

Biogen (BIIB) has an impressive earnings surprise history and currently possesses the right...

Zacks · via Yahoo Finance 29 Jan 2025

Sage Therapeutics turns down Biogen's offer to buy the remaining stake in the company and is...

Zacks · via Yahoo Finance 28 Jan 2025

The FDA's approval is based on simulation data from multiple studies showing that maintenance dos...

Zacks · via Yahoo Finance 27 Jan 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) stock climbed 2.5% today, reflecting investor sentiment aft...

Investing.com 27 Jan 2025

Free Report) announced that the FDA has approved a monthly maintenance dosing version for its...

Zacks 27 Jan 2025

AbbVie Inc. Price AbbVie Inc. price | AbbVie Inc. Quote ABBV’s Zacks Rank AbbVie currently carrie...

Zacks · via Yahoo Finance 24 Jan 2025

BIIB's regulatory filings are supported by late-stage data, which show that treatment with a high...

Zacks · via Yahoo Finance 24 Jan 2025

Shares of Ionis Pharmaceuticals (NASDAQ:IONS) climbed 7% today after the company announced that...

Investing.com 23 Jan 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.52%

Investing.com 14 Jan 2025